Next 10 |
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome showing that when tumors exhibited higher overall numbers of structural varia...
Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical genome mapping (OGM) and findings from early access customers The pre-conference event will also include a 2024 corporate overvi...
2024-03-06 00:30:12 ET Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO) Q4 2023 Earnings Call Mar 05, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
2024-03-05 21:54:02 ET Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Conference Call March 5, 2024 16:30 ET Company Participants David Holmes - Investor Relations Erik Holmlin - Chief Executive Officer Gulsen Kama - Chief Financial Officer Conference Call ...
Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022 FY 2023 revenue was $36.1 million, which represents a 30% increase over FY 2022 Reached installed base of 326 optical genome mapping (OGM) systems as of YE 2023; increase of 36% over the 240 installed systems ...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s 44 th Annual Health Care Conference on March 6, 2024. Conference &a...
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 5, 2024, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2023 and to h...
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (“Bionano”) (Nasdaq: BNGO) today announced that is has amended the convertible debt financing the company entered into in October 2023 pursuant to which the company agreed to issue and sell to a certain accredited i...
2024-02-07 13:10:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now might be a good time to consider scooping up shares of penny stocks to buy on the dip. However, caution is essential, as penny stocks can be volatile and speculative. So to help reduce ...
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome showing that when tumors exhibited higher overall numbers of structural varia...
Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical genome mapping (OGM) and findings from early access customers The pre-conference event will also include a 2024 corporate overvi...
2024-03-06 00:30:12 ET Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO) Q4 2023 Earnings Call Mar 05, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript